Cover Image

SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome?

Saved in:

Bibliographic Details
Main Authors:	Alizay Rashid Khan MBBS (Author), Muhammad Osama Farooqui MBBS (Author), Rohan Kumar Ochani MBBS (Author)
Format:	Book
Published:	SAGE Publishing, 2020-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2: an environmental trigger of Darier's disease?
by: Diego Orsini, et al.
Published: (2023)

Recalcitrant verruca vulgaris regression following severe SARS-CoV-2 infection
by: Devin Barzallo, BA, et al.
Published: (2022)

SARS‐CoV‐2 infection as a trigger of autoimmune response
by: Maria C. Sacchi, et al.
Published: (2021)

Delayed Kawasaki disease in an adult previously infected with SARS-CoV-2
by: Sheila Wang, MD, PhD, et al.
Published: (2022)

Incomplete Kawasaki Disease in an Adult South Asian Patient
by: Neetu Boodoosingh MBBS, et al.
Published: (2018)

SARS-CoV-2-Triggered Hemophagocytic Lymphohistiocytosis with Complications of Posterior Reversible Encephalopathy Syndrome
by: Ross M. Perry, et al.
Published: (2024)

SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema
by: Mike Fritz, BS, et al.
Published: (2021)

Potential link between SARS-CoV-2 and Kawasaki disease: importance of dentists for the diagnosis
by: Hercílio Martelli Júnior, et al.
Published: (2021)

Decreased incidence of Kawasaki disease in South Korea during the SARS-CoV-2 pandemic
by: Kyung Jin Oh, et al.
Published: (2024)

A Comparison of Kawasaki Disease during the SARS-CoV-2 Pandemic with Multisystem Inflammatory Syndrome in Children
by: Tunç Tunçer, et al.
Published: (2024)

VA-Wide, Multicenter Verification Study of the Cepheid Xpert SARS-CoV-2 Assay
by: Mohammad Obeidat MBBS, et al.
Published: (2021)

Response to "Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases"
by: Ziying Vanessa Lim, MBBS, MRCP, MMed, et al.
Published: (2022)

Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications
by: Da Eun Roh, et al.
Published: (2022)

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey
by: Marco Cattalini, et al.
Published: (2021)

SARS-CoV-2 infection-triggered juvenile dermatomyositis in a preschool male child: A rare presentation
by: Vivek Kumar, et al.
Published: (2023)

How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress
by: Annamaria Vernone, et al.
Published: (2023)

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
by: Catherine Chen, et al.
Published: (2021)

A Case of Kawasaki Disease With Concomitant Leptospirosis
by: Caleb Chuan Yao Foo, et al.
Published: (2017)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020)

Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2
by: Wenjiang Zheng, et al.
Published: (2021)

Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain
by: Elisa Fernández-Cooke, et al.
Published: (2021)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
by: Amjad Ali, et al.
Published: (2023)

Cytokine Response in SARS-CoV-2 Infection in the Elderly
by: Sherwani S, et al.
Published: (2020)

Transfusion-Related Acute Lung Injury After Immunoglobulin Infusion for Kawasaki Disease: A Case Report and Literature Review
by: Judy Ibrahim MBBS, et al.
Published: (2017)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Human-Animal Interaction and the Emergence of SARS-CoV-2
by: Hassani, Asma, et al.
Published: (2020)

SARS-CoV-2 Infection as a Possible Trigger for IgA-Associated Vasculitis: A Case Report
by: Edyta Machura, et al.
Published: (2023)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study
by: Liu, Boxiang, et al.
Published: (2020)

A Case of Atypical Kawasaki Disease With Myositis
by: Elis Yuexian Lee, et al.
Published: (2015)

New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic
by: Nikky Goel, et al.
Published: (2021)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
by: Khan Sharun, et al.
Published: (2020)

Analysis of C-reactive protein level in SARS-CoV-2 patients and its role in predicting the severity of SARS-CoV-2 infection
by: Rozina Arshi Khan, et al.
Published: (2023)

SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
by: Bai, Francesca
Published: (2021)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)